Save
PB0310 Arterial Ischemic Stroke Related to Minor Head Trauma: A Report of Five Pediatric Cases
ISTH Academy, Faculty / Presenters, 407214
PB0309 Safety and Efficacy of Apixaban Therapy in an Obese Adolescent with Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407215
PB0308 Anticoagulation Monitoring of UFH (Unfractioned Heparin) in a Pediatric Patient during Long Term ECMO (Extracorporeal Membrane Oxygenation)
ISTH Academy, Faculty / Presenters, 407216
PB0307 Pediatric Pulmonary Embolism and Pulmonary Hypertension Associated with E-Cigarette use
ISTH Academy, Faculty / Presenters, 407217
PB0306 Thromboprophylaxis in Pediatric Patient with Acute Lymphoblastic Leukemia and Treatment with Asparaginase
ISTH Academy, Faculty / Presenters, 407218
PB0304 Bivalirudin Anticoagulation for an Infant with Heparin Resistance on ECMO
ISTH Academy, Faculty / Presenters, 407219
PB0300 Diagnosis of Thromboembolism in Children with Cancer: Validation of Diagnostic Algorithms Using Real-World Data
ISTH Academy, Faculty / Presenters, 407220
PB0301 Ocular Vein Occlusion in Pediatrics: Should Thrombophilia Investigation and Anticoagulant Treatment be Initiated?
ISTH Academy, Faculty / Presenters, 407221
PB0302 Preventing Thrombosis in Moderate-Severe Protein C Deficiency: The Effects of Different Treatment Regimensin a Boywith Protein C Level of 4 IU/dl
ISTH Academy, Faculty / Presenters, 407222
PB0297 Antiphosphatidylserine/Prothrombin Antibodies in Childhood SLE are Associated with Lupus Anticoagulant Positivity
ISTH Academy, Faculty / Presenters, 407223
PB0298 Catheter-Directed Thrombolysis and Systemic Anticoagulation for IVC and Bilateral Renal Vein Thrombosis in a Septic Neonate
ISTH Academy, Faculty / Presenters, 407224
PB0299 Surface Modification of Lung Assist Device for Neonates by Dual-Modification with Antithrombin-Heparin (ATH) and Tissue Plasminogen Activator (t-PA)
ISTH Academy, Faculty / Presenters, 407225
PB0293 Development of a Pediatric Pulmonary Embolism Response Team: An Institutional Experience
ISTH Academy, Faculty / Presenters, 407226
PB0294 Incidence of Venous Thromboembolism (VTE) in Adventh-Pediatric Registry in a Southeastern Brazilian City
ISTH Academy, Faculty / Presenters, 407227
PB0295 Off-Label Use of Rivaroxaban in the Management of Three Cases of Pediatric Arterial Ischemic Stroke
ISTH Academy, Faculty / Presenters, 407228
PB0288 Antiphospholipid Syndrome in Children: 30 Years Single-Center Prospective Pediatric Cohort from Argentina
ISTH Academy, Faculty / Presenters, 407229
PB0289 Association of Elevated Coagulation Factors VIII, IX and XI with Recurrent Thrombotic Events in Children with Non-Central Venous Line Deep Vein Thrombosis
ISTH Academy, Faculty / Presenters, 407230
PB0290 Bleeding Complications in Children with Myeloproliferative Neoplasms and Thrombosis on Anticoagulation
ISTH Academy, Faculty / Presenters, 407231
PB0291 Clinical Manifestations, Treatment and Outcomes of Pediatric Portal Vein Thrombosis
ISTH Academy, Faculty / Presenters, 407232
PB0292 Thrombotic Risk Evaluation in Pediatric Patients with Acute Lymphoblastic Leukemia Using Thrombin Generation Test
ISTH Academy, Faculty / Presenters, 407233
PB0287 Thromboembolic and Hemorrhagic Events in Pediatric Patients Assisted with Mechanical Circulatory Support and Bivalirudin Anticoagulation: A Retrospective Observational Study
ISTH Academy, Faculty / Presenters, 407234
PB0281 Establishment of a National Patient-Based Pediatric Thrombosis Registry by Iranian Society of Thrombosis and Hemostasis
ISTH Academy, Faculty / Presenters, 407235
PB0286 Population Pharmacokinetics and Pharmacodynamics of Bivalirudin in Children on Ventricular Assist Device Support
ISTH Academy, Faculty / Presenters, 407236
PB0282 Evaluation of Plasma Coagulative and Fibrinolytic Function in Critically Ill Children with COVID-19 or MIS-C An Analysis of the COVAC-TP Trial
ISTH Academy, Faculty / Presenters, 407237
PB0283 Impact of An Institutional Anticoagulant Thromboprophylaxis Protocol in Hospitalized Pediatric Patients with Inflammatory Bowel Disease at High Risk for Venous Thromboembolism
ISTH Academy, Faculty / Presenters, 407238
PB0284 Resolution Rates of Provoked Venous Thrombus Embolism in Pediatric Patients Managed at a Tertiary Care Center
ISTH Academy, Faculty / Presenters, 407239
PB0285 Use of Systemic Thrombolysis in Pediatric Cardiac-Related Thrombosis; A Retrospective Cohort Study
ISTH Academy, Faculty / Presenters, 407240
PB0279 Intermediate- and High-Risk Pulmonary Embolism in Pediatric Tertiary Care Centers in the Netherlands. Is there a need for a Pediatric PERT?
ISTH Academy, Faculty / Presenters, 407241
PB0277 Outcomes of Cerebrosinovenous Thrombosis in Infants and Children
ISTH Academy, Faculty / Presenters, 407242
PB0278 Pediatric Renal Tumors: Clinical Outcomes in Patients with and without Tumor-Related Thrombus
ISTH Academy, Faculty / Presenters, 407243
PB1355 Long Vaccine-Induced Immune Thrombotic Thrombocytopenia: A Case Report
ISTH Academy, Faculty / Presenters, 407244
PB1352 A Survey on Anticoagulation in Patient with ITP
ISTH Academy, Faculty / Presenters, 407245
PB1349 Clinical Relevance and Management of Bleeding in Patients with Myelodysplastic Syndromes and Severe Thrombotytopenia: A Retrospective Analysis
ISTH Academy, Faculty / Presenters, 407246
PB1351 High-Doses of Dexamethasone as an Alternative to Other Steroidal Use in Primary Immune Thrombocytopenia Cases: A Research Study in a Salvadoran Population
ISTH Academy, Faculty / Presenters, 407247
PB1346 A New Canine Thrombopoietin Assay Reveals Common Pathogenesis of Canine and Human Immune Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407248
PB1347 Evaluating Local Practice Patterns and IVIg Use to Treat Immune Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407249
PB1348 Thrombopoietin Receptor Agonist and Rituximab Combination Therapy in Patients with Refractory Primary Immune Thrombocytopenia. A Single-Center Study
ISTH Academy, Faculty / Presenters, 407250
PB1345 Health-Related Quality of Life Assessed by the SF-36 Health Survey in the Vienna ITP Biobank
ISTH Academy, Faculty / Presenters, 407251
PB1342 Clinical Significance of Anti-Nuclear Antibody Positivity in Immune Thrombocytopenia Purpura in Adults
ISTH Academy, Faculty / Presenters, 407252
PB1344 Impact of Spleen Tyrosine Kinase Inhibition on Vaccine-Induced Thrombotic Thrombocytopenia Antibody-Induced Procoagulant Platelet and Thrombus Formation
ISTH Academy, Faculty / Presenters, 407253
PB1341 Obinutuzumab-Induced Thrombocytopenia: An Under-Recognized Immunotherapy Related Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407254
PB1336 Novel Insight into Platelet Refractoriness: Desialylation, Apoptosis and Treatment
ISTH Academy, Faculty / Presenters, 407255
PB1338 Thrombotic Thrombocytopenia Syndrome after vaccination against COVID-19 Associated with Antiplatelet Antibodies
ISTH Academy, Faculty / Presenters, 407256
PB1332 Heightened Thrombosis in Immune Thrombocytopenia: Insights into the Risk Factors and Clinical Outcomes from an Australian Hospital Cohort
ISTH Academy, Faculty / Presenters, 407257
PB1334 Safety Profile of Efgartigimod from Clinical Trials in Participants with Immunoglobulin G-Mediated Autoimmune Diseases
ISTH Academy, Faculty / Presenters, 407258
PB0337 Occult Cervical Cancer-Induced Refractory Thrombotic Thrombocytopenic Purpura in a Renal Transplant Patient with Low- level Cytomegalovirus Viremia: A Case Report
ISTH Academy, Faculty / Presenters, 407259
PB0336 Refractory Thrombotic Thrombocytopenic Purpura Treated by Discontinuation of Therapeutic Plasma Exchange
ISTH Academy, Faculty / Presenters, 407260
PB0334 Immune-Mediated Thrombotic Thrombocytopenic Purpura Landscaping in Gulf Countries: A Real-World Evidence Study (ATHENA Study)
ISTH Academy, Faculty / Presenters, 407261
PB0335 Medical Education in Congenital Thrombotic Thrombocytopenic Purpura Significantly Improves Competence in Making Appropriate Management Choices
ISTH Academy, Faculty / Presenters, 407262
PB0332 Hereditary Thrombotic Thrombocytopenic Purpura: A Survey of Canadian Treaters
ISTH Academy, Faculty / Presenters, 407263
PB0333 Therapeutic Plasma Exchange-Related Complications in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura
ISTH Academy, Faculty / Presenters, 407264
PB0330 Relevance of ADAMTS13 Antigenic Levels in the Characterization of Pathological Mechanisms Associated with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP)
ISTH Academy, Faculty / Presenters, 407265
PB0327 Modulating ADAMTS13 Activity Using Organic Solvents
ISTH Academy, Faculty / Presenters, 407266
PB0328 Outcomes of Immune-Mediated Thrombotic Thrombocytopenic Purpura at a Single Center in Japan
ISTH Academy, Faculty / Presenters, 407267
PB0324 Burden of Symptoms and Healthcare Resource Utilization (HCRU) and Costs in U.S. Patients with Thrombotic Thrombocytopenic Purpura (TTP)
ISTH Academy, Faculty / Presenters, 407268
PB0325 How Rare is Rare? The First Epidemiological Study of Thrombotic Thrombocytopenic Purpura (TTP) in a Large Canadian City
ISTH Academy, Faculty / Presenters, 407269
PB0326 Incidence of Thrombotic Thrombocytopenic Purpura and Other Suspected Thrombotic Microangiopathies during the COVID-19 Pandemic Period 2020-2021 in Quebec
ISTH Academy, Faculty / Presenters, 407270
PB0322 Burden of Illness Associated with Congenital Thrombotic Thrombocytopenic Purpura: A Systematic Review
ISTH Academy, Faculty / Presenters, 407271
PB0323 Preliminary Analysis of ATHN 16: Real-World Safety of Eptacog Beta
ISTH Academy, Faculty / Presenters, 407272
PB0321 Prospective Evaluation of the HemosIL AcuStar ADAMTS13 Activity Assay
ISTH Academy, Faculty / Presenters, 407273
PB0318 Evaluation of a Novel ADAMTS13 Activity Reagent Using Fully Automated Analyzer
ISTH Academy, Faculty / Presenters, 407274
PB0319 Overexpression of ANKRD26 Results in Thrombocytopenia That May Exacerbate Clinical Phenotypes of Thrombotic Thrombocytopenic Purpura
ISTH Academy, Faculty / Presenters, 407275
PB0320 Understanding the Contribution of Single Synonymous Variants to ADAMTS13 Functionality
ISTH Academy, Faculty / Presenters, 407276
PB0316 Bortezomib for the Treatment of Multi-Refractory Immune-Mediated Thrombotic Thrombocytopenic Purpura: An Italian Multicenter Survey
ISTH Academy, Faculty / Presenters, 407277
PB0315 Characterizing Protease-Resistant ADAMTS13 Mutants
ISTH Academy, Faculty / Presenters, 407278
PB0317 Novel Luminescent-Based ADAMTS13 Activity Assay
ISTH Academy, Faculty / Presenters, 407279
PB0314 Treatment Delay and Outcomes in Elderly TTP Patients: A Nationwide Analysis
ISTH Academy, Faculty / Presenters, 407280
PB0312 Assessment of Post-Treatment Anti-Drug Antibodies to Caplacizumab in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura
ISTH Academy, Faculty / Presenters, 407281
PB0313 Towards the Standardisation of ADAMTS-13 Antibody Testing in Thrombotic Thrombocytopenic Purpura (TTP)-Results of the IMATAS Collaborative Study
ISTH Academy, Faculty / Presenters, 407282
PB0338 The Ideal Acetylsalicylic Acid (ASA) Dose to Combine with P2Y12 Inhibitors: A Volunteer Study
ISTH Academy, Faculty / Presenters, 407283
PB0354 Use of Intraoperative Heparin in Combination with Cangrelor in Patients with Acute Heparin-Induced Thrombocytopenia Undergoing Cardiopulmonary Bypass for Heart Transplantation: A Case Series
ISTH Academy, Faculty / Presenters, 407284
PB0353 Flow Cytometry Detection of Procoagulant Platelets: A Diagnostic Test for Heparin Induced Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407285
PB0352 Non-Pathogenic Anti-PF4 Antibodies after SARS-CoV-2 Vaccines: Long Term Follow-Up
ISTH Academy, Faculty / Presenters, 407286
PB0351 Complement Activating Properties of Heparin Induced Thrombocytopenia (HIT) Antibodies as Surrogate Markers for Functional Assays
ISTH Academy, Faculty / Presenters, 407287
PB0349 Anti-PF4-Antibodies in Patients Suspected of Vaccine-Induced Immune Thrombotic Thrombocytopenia After SARS-CoV-2 Vaccination
ISTH Academy, Faculty / Presenters, 407288
PB0350 Prospective Study to Evaluate the Consolidated Performance of Two Automated Rapid Assays for the Diagnosis of Heparin-Induced Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407289
PB0348 Can 5B9, a Monoclonal Antibody to PF4/H, be Useful in Improving the Performance of the Asserachrom HPIA Test for the Diagnosis of HIT?
ISTH Academy, Faculty / Presenters, 407290
PB0347 Argatroban or Bivalirudin for Suspected or Confirmed Heparin Induced Thrombocytopenia at a Large Academic Medical Center
ISTH Academy, Faculty / Presenters, 407291
PB0346 Monoclonal Gammopathy of Thrombotic/Thrombocytopenic Significance
ISTH Academy, Faculty / Presenters, 407292
PB0345 Diagnosing Heparin-Induced Thrombocytopenia: A Prospective Multicentre Study
ISTH Academy, Faculty / Presenters, 407293
PB0343 Longitudinal Study on the Persistence of Anti-Platelet Factor 4 Antibodies in Vaccine-Induced Immune Thrombotic Thrombocytopenia after 14 Months
ISTH Academy, Faculty / Presenters, 407294
PB0344 The Impact of Spleen Tyrosine Kinase-Inhibition on 5B9 HIT Antibody-Induced Procoagulant Platelet Formation
ISTH Academy, Faculty / Presenters, 407295
PB0342 Platelet Phosphatidylserine is the Critical Mediator of Thrombosis in Heparin-Induced Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407296
PB0805 Comparison of Three ELISA Assays for the Detection and Quantification of Autoantibodies against Complement Factor H
ISTH Academy, Faculty / Presenters, 407297
PB0804 Eculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated Atypical Hemolytic Uremic Syndrome: Retrospective Cohort Study
ISTH Academy, Faculty / Presenters, 407298
PB0358 Hereditary Bleeding Disorders Web-Based Registry of Patients with Inherited Platelet Disorders
ISTH Academy, Faculty / Presenters, 407299
PB0357 Hereditary Thrombocytopenia with Platelet Sialic Acid Deficiency and Mutations in the GNE Genes
ISTH Academy, Faculty / Presenters, 407300
PB0356 Results of Local Implementation of Next Generation Sequencing (NGS) for Diagnosis of Inherited Thrombocytopenias (IT) in Argentina
ISTH Academy, Faculty / Presenters, 407301
PB0355 Knock-in of Homozygous NBEAL2 Variants to Model Gray Platelet Syndrome in Megakaryocytes Derived from CRISPR-Cas9-edited Pluripotent Stem Cells
ISTH Academy, Faculty / Presenters, 407302
PB0363 A Case Report of Quinine-Induced Thrombotic Microangiopathy Treated with Eculizumab
ISTH Academy, Faculty / Presenters, 407303
PB0362 Atypical Hemolytic Uremic Syndrome after SARS-CoV2 Infection with C3 p.I1157 T Mutation
ISTH Academy, Faculty / Presenters, 407304
PB0367 Heavy Menstrual Bleeding in Paediatric Patient due to Resistant Chronic Immune Thrombocytopenia Successfully Treated with Eltrombopag and Tranexemic Acid - a Case Report Form Bosnia and Herzegovina
ISTH Academy, Faculty / Presenters, 407305
PB0366 Ticagrelor Overdose Managed without Adverse Outcomes: Is Reversal Agent Necessary?
ISTH Academy, Faculty / Presenters, 407306
PB0365 A Novel and Potent Collagen Antagonist, Niclosamide in Human Platelets: In Vitro and In Vivo Studies
ISTH Academy, Faculty / Presenters, 407307
PB0364 Glycoprotein VI-Targeted Antiplatelet Therapy with Glenzocimab is Safe in Patients Exposed to Current Antithrombotic and Fibrinolytic Drugs
ISTH Academy, Faculty / Presenters, 407308
PB1371 Platelet Activation with the Aeson Bioprosthetic Total Artificial Heart: Insight from Aspirin Treatment and Outcomes
ISTH Academy, Faculty / Presenters, 407309
PB1368 Platelet Subpopulations in Decompensated Cirrhotic Children
ISTH Academy, Faculty / Presenters, 407310
PB1369 Relevance of the Absence of Integrin αIIb Expression by Flow Cytometry in Acquired Glanzmann's Thrombasthenia
ISTH Academy, Faculty / Presenters, 407311
PB1370 Thrombocytosis and Acquired Bleeding Disorders in Patients with Myeloproliferative Neoplasms
ISTH Academy, Faculty / Presenters, 407312
PB1366 Characteristics of Platelets in Elderly Patients with Immune Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407313

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings